Company Overview

C2N is a specialty diagnostics company providing exceptional laboratory services and products in the field of brain health.  C2N’s high-resolution mass spectrometry-based biomarker products are used for: clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiological studies to improve global public health.